Previsioni di mercato per la somministrazione di farmaci oculari in Europa fino al 2028 - Impatto del COVID-19 e analisi regionale per tecnologia (sistemi di somministrazione di farmaci oculari impiantabili, sistemi di somministrazione di farmaci particolati, sistemi di somministrazione di farmaci con nanoparticelle e altri), tipo di formulazione (liposomi e nanoparticelle, soluzione, emulsione, sospensione e unguento), tipo di malattia (glaucoma, retinopatia diabetica, sindrome dell\'occhio secco, degenerazione maculare, cataratta, edema maculare diabetico e altri) e utente finale (ospedali, cliniche oftalmiche e centri chirurgici ambulatoriali)

Introduzione al mercato

Il mercato europeo della somministrazione di farmaci oculari è segmentato in Germania, Regno Unito, Francia, Italia, Spagna e resto d\'Europa, e la Germania deteneva la quota maggiore del mercato. Il notevole aumento della popolazione geriatrica della Germania rappresenta un\'opportunità redditizia per una maggiore adozione del mercato della somministrazione di farmaci oculari nel paese. Secondo la preparazione all\'invecchiamento e la preparazione all\'invecchiamento. Competitiveness Initiative, si prevede che la popolazione tedesca di età pari o superiore a 65 anni crescerà del 41% fino a raggiungere 24 milioni entro il 2050, rappresentando quasi un terzo della popolazione totale. Inoltre, un numero elevato di pazienti che convivono con disturbi oculari stanno guidando la crescita del mercato. Secondo l\'EEIG dell\'European Vision Institute, in Germania circa 30.000 persone sono affette da disturbi ereditari della retina. La crescente digitalizzazione e l’uso estensivo di piccoli dispositivi mobili hanno portato a difetti della vista in età più giovane, sostenendo le vendite di lenti a contatto. Inoltre, il Paese dispone di un solido supporto tecnologico per i dispositivi medici; il paese ha diverse aziende che si dedicano alla lavorazione di dispositivi medici sofisticati. Inoltre, è probabile che la presenza di operatori di mercato nel paese aumenti la consapevolezza e la portata del prodotto sul mercato. Novaliq è un\'azienda farmaceutica oftalmica tedesca e sta sviluppando la prima tecnologia senza acqua per la somministrazione di farmaci oculari. Novaliq è focalizzata sullo sviluppo della tecnologia da utilizzare nei trattamenti per la malattia dell’occhio secco. I prodotti dell\'azienda sono incentrati sulla sua tecnologia proprietaria priva di acqua, EyeSol per la somministrazione di farmaci topici oculari.

La regione europea è stata pesantemente colpita dalla diffusione del COVID-19, con la maggior parte dei paesi in lockdown. I servizi sanitari di routine sono stati cancellati e ai pazienti è stato raccomandato di evitare le visite ospedaliere per ridurre al minimo il rischio di trasmissione di COVID-19, con conseguenti interruzioni significative nella fornitura del servizio sanitario e nella cura dei pazienti. L\'oftalmologia rappresenta una delle specialità più attive e fortemente orientate al trattamento ambulatoriale, con circa 7,5 milioni di visite ambulatoriali e oltre 500.000 procedure chirurgiche eseguite ogni anno nel Regno Unito. Il lockdown ha comportato la cancellazione di migliaia di visite e interventi chirurgici oftalmici; ciò ha potenzialmente portato a danni permanenti e significativi alla vista del paziente. Inoltre, secondo il recente sondaggio, – \"L\'impatto psicosociale del blocco dovuto alla pandemia di COVID-19 sulle persone che vivono con malattie degli occhi nel Regno Unito\" che è stato condotto tra il pubblico con malattie degli occhi, ha evidenziato un significativo impatto psicosociale negativo del blocco sui pazienti con disabilità visive, con circa il 50% dei pazienti che esprime paura di perdere la vista a causa di una revisione o di un trattamento ritardati.

Panoramica e dinamiche del mercato

Si prevede che il mercato della somministrazione di farmaci oculari in Europa crescerà di 7.921,15 milioni di dollari entro il 2028 rispetto a 4.967,64 milioni di dollari nel 2021. Si stima che il mercato crescerà a un CAGR del 6,9% dal 2021 al 2028. Cataratta, glaucoma, degenerazione maculare legata all’età, retinopatia diabetica e errore di rifrazione non risolto sono tra le principali cause di cecità o ipovisione. La maggior parte della popolazione ha o ha avuto qualche disturbo agli occhi nel corso della propria vita. Secondo il rapporto dell’Organizzazione Mondiale della Sanità (OMS) “Cecità e disturbi della vista”, pubblicato nel febbraio 2021, circa 2,2 miliardi di persone in tutto il mondo hanno problemi di vista da vicino o da lontano. Si stima inoltre che la principale causa di perdita della vista o ipovisione sia la cataratta (94 milioni) e gli errori di rifrazione non corretti (88,4 milioni). Inoltre, le altre cause comuni di perdita della vista sono il glaucoma (7,7 milioni), le opacità corneali (4,2 milioni), la retinopatia diabetica (3,9 milioni) e il tracoma (2 milioni). Secondo il Royal National Institute of Blind People nel 2017, nel Regno Unito erano circa 350.000 le persone registrate come cieche e ipovedenti; circa 173.735 sono quelli registrati come gravemente ipovedenti; e 176.125 erano registrati come non vedenti. Pertanto, la crescente prevalenza dei disturbi oculari sta guidando il mercato della somministrazione di farmaci oculari.

Segmenti chiave del mercato

Farmaci oculari in Europa Il mercato della consegna è segmentato in base alla tecnologia, al tipo di formulazione, al tipo di malattia e all’utente finale. In base alla tecnologia, il segmento dei sistemi di somministrazione di farmaci oculari impiantabili ha rappresentato la quota più elevata nel 2021. In base al tipo di formulazione, il segmento delle soluzioni ha rappresentato la quota più elevata nel 2021. In base al tipo di malattia, il segmento della cataratta ha rappresentato la quota più elevata nel 2021. In base a il segmento degli ospedali per gli utenti finali ha rappresentato la quota più elevata nel 2021.

Principali fonti e aziende elencate

Alcune principali fonti primarie e Le fonti secondarie a cui si fa riferimento per la preparazione del presente rapporto sul mercato della somministrazione di farmaci oculari in Europa sono siti Web aziendali, relazioni annuali, relazioni finanziarie, documenti governativi nazionali e database statistici, tra gli altri. Principali aziende elencate nel rapporto AbbVie Inc.; Bausch Health Companies Inc.; Novartis AG; Clearside Biomedical, Inc.; Terapia Envisia; GRAYBUG VISION, INC tra gli altri.

Rapporto sui motivi per acquistare

Risparmia e riduci il tempo svolgendo ricerche entry-level identificando la crescita, le dimensioni, gli attori e i segmenti leader nel mercato europeo della somministrazione di farmaci oculari
Punti salienti priorità aziendali al fine di aiutare le aziende a riallineare le proprie strategie aziendali
I risultati e le raccomandazioni chiave evidenziano le tendenze cruciali e progressiste del settore nel mercato europeo della somministrazione di farmaci oculari, consentendo così agli attori lungo tutta la catena del valore di sviluppare strategie efficaci a lungo termine
Sviluppare/modificare i piani di espansione aziendale utilizzando una crescita sostanziale offerta dai mercati sviluppati ed emergenti
Esaminare in modo approfondito le tendenze e le prospettive del mercato europeo insieme ai fattori che guidano anche il mercato della somministrazione di farmaci oculari come coloro che lo ostacolano
Migliorare il processo decisionale comprendendo le strategie che sostengono l\'interesse commerciale rispetto ai prodotti dei clienti, alla segmentazione, ai prezzi e alla distribuzione

Segmentazione del mercato europeo della somministrazione di farmaci oculari

Mercato europeo della somministrazione di farmaci oculari - Per tecnologia

Sistemi di somministrazione di farmaci oculari impiantabili
Sistemi di somministrazione di farmaci in particolato
Sistema di somministrazione di farmaci con nanoparticelle
Altri

< span>Mercato europeo della somministrazione di farmaci oculari - Per tipo di formulazione

Soluzione
Unguento
Sospensione
Emulsione
Liposomi e nanoparticelle

< p>Mercato europeo della somministrazione di farmaci oculari - Per tipo di malattia

Europa Mercato della somministrazione di farmaci oculari - Per utente finale

Ospedali
Cliniche oftalmiche
Centri chirurgici ambulatoriali

Mercato europeo della somministrazione di farmaci oculari - Per paese

Mercato europeo della somministrazione di farmaci oculari - Aziende menzionate

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Europe Ocular Drug Delivery Market – By Technology

1.3.2 Europe Ocular Drug Delivery Market – By Formulation Type

1.3.3 Europe Ocular Drug Delivery Market – By Disease Type

1.3.4 Europe Ocular Drug Delivery Market – By End User

1.3.5 Europe Ocular Drug Delivery Market – By Country

2. Europe Ocular Drug Delivery Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Ocular Drug Delivery Market – Market Landscape

4.1 Overview

4.2 Expert Opinions

5. Europe Ocular Drug Delivery Market– Key Market Dynamics

5.1 Market Drivers

5.1.1 Surging Prevalence of Eye Disorders

5.2 Market Restraints

5.2.1 Drawbacks Associated with Ocular Drug Delivery

5.3 Market Opportunities

5.3.1 Raising Awareness About Vision Care

5.4 Future Trends

5.4.1 Emergence of Innovative Products

5.5 Impact analysis

6. Europe Ocular Drug Delivery – Market Analysis

6.1 Europe Ocular Drug Delivery Market Revenue Forecast and Analysis

7. Europe Ocular Drug Delivery Market Analysis – By Technology

7.1 Overview

7.2 Europe Ocular Drug Delivery Market Share by Technology 2021 & 2028 (%)

7.3 Implantable Ocular Drug Delivery Systems

7.3.1 Overview

7.3.2 Implantable Ocular Drug Delivery Systems Market Revenue and Forecast to 2028 (US$ Million)

7.4 Particulate Drug Delivery Systems

7.4.1 Overview

7.4.2 Particulate Drug Delivery Systems Market Revenue and Forecast to 2028 (US$ Million)

7.5 Nano-Particle Drug Delivery System

7.5.1 Overview

7.5.2 Nano-Particle Drug Delivery System Market Revenue and Forecast to 2028 (US$ Million)

7.6 Others

7.6.1 Overview

7.6.2 Others Market Revenue and Forecast to 2028 (US$ Million)

8. Europe Ocular Drug Delivery Market Analysis – By Formulation Type

8.1 Overview

8.1.1 Europe Ocular Drug Delivery Market, By Formulation Type 2021 & 2028 (%)

8.2 Liposomes and Nanoparticles Market

8.2.1 Overview

8.2.2 Liposomes and Nanoparticles Market Revenue and Forecasts to 2028 (US$ Million)

8.3 Solution

8.3.1 Overview

8.3.2 Solution Market Revenue and Forecasts to 2028 (US$ Million)

8.4 Emulsion

8.4.1 Overview

8.4.2 Emulsion Market Revenue and Forecasts to 2028 (US$ Million)

8.5 Suspension

8.5.1 Overview

8.5.2 Suspension Market Revenue and Forecasts to 2028 (US$ Million)

8.6 Ointment

8.6.1 Overview

8.6.2 Ointment Market Revenue and Forecasts to 2028 (US$ Million)

9. Europe Ocular Drug Delivery Market Analysis – By Disease Type

9.1 Overview

9.2 Europe Ocular Drug Delivery Market Share by Disease Type 2021 & 2028 (%)

9.3 Cataract

9.3.1 Overview

9.3.2 Cataract Market Revenue and Forecast to 2028 (US$ Million)

9.4 Dry Eye Syndrome

9.4.1 Overview

9.4.2 Dry Eye Syndrome Market Revenue and Forecast to 2028 (US$ Million)

9.5 Macular Degeneration

9.5.1 Overview

9.5.2 Macular Degeneration Market Revenue and Forecast to 2028 (US$ Million)

9.6 Glaucoma

9.6.1 Overview

9.6.2 Glaucoma Market Revenue and Forecast to 2028 (US$ Million)

9.7 Diabetic Retinopathy

9.7.1 Overview

9.7.2 Diabetic Retinopathy Market Revenue and Forecast to 2028 (US$ Million)

9.8 Diabetic Macular Edema

9.8.1 Overview

9.8.2 Diabetic Macular Edema Market Revenue and Forecast to 2028 (US$ Million)

9.9 Others

9.9.1 Overview

9.9.2 Others Market Revenue and Forecast to 2028 (US$ Million)

10. Europe Ocular Drug Delivery Market Analysis – By End User

10.1 Overview

10.2 Europe Ocular Drug Delivery Market Share, by End User, 2021 and 2028 (%)

10.3 Hospitals

10.3.1 Overview

10.3.2 Hospitals: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)

10.4 Ophthalmic Clinics

10.4.1 Overview

10.4.2 Ophthalmic Clinics: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)

10.5 Ambulatory Surgical Centers

10.5.1 Overview

10.5.2 Ambulatory Surgical Centers: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)

11. Europe Ocular Drug Delivery Market – Country Analysis

11.1 Overview

11.1.1 Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Country (%)

11.1.1.1 Germany Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.1.1 Germany Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.1.2 Germany Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Million)

11.1.1.1.3 Germany Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million)

11.1.1.1.4 Germany Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million)

11.1.1.1.5 Germany Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User (US$ Million)

11.1.1.2 UK Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.2.1 UK Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.2.2 UK Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Million)

11.1.1.2.3 UK Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million)

11.1.1.2.4 UK Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million)

11.1.1.2.5 UK Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User (US$ Million)

11.1.1.3 France Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.3.1 France Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.3.2 France Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Million)

11.1.1.3.3 France Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million)

11.1.1.3.4 France Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million)

11.1.1.3.5 France Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User (US$ Million)

11.1.1.4 Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.4.1 Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.4.2 Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Million)

11.1.1.4.3 Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million)

11.1.1.4.4 Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million)

11.1.1.4.5 Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User (US$ Million)

11.1.1.5 Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.5.1 Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.5.2 Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Million)

11.1.1.5.3 Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million)

11.1.1.5.4 Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million)

11.1.1.5.5 Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User (US$ Million)

11.1.1.6 Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.6.1 Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.6.2 Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Million)

11.1.1.6.3 Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million)

11.1.1.6.4 Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million)

11.1.1.6.5 Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User (US$ Million)

12. Impact Of COVID-19 Pandemic on Europe Ocular Drug Delivery Market

12.1 Impact Assessment of COVID-19 Pandemic

13. Industry Landscape

13.1 Overview

13.2 Organic Developments

13.2.1 Overview

13.3 Inorganic Developments

13.3.1 Overview

14. Company Profiles

14.1 AbbVie Inc.

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 Bausch Health Companies Inc.

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Products and Services

14.2.4 Financial Overview

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 GRAYBUG VISION, INC.

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Products and Services

14.3.4 Financial Overview

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 Alimera Sciences, Inc.

14.4.1 Key Facts

14.4.2 Business Description

14.4.3 Products and Services

14.4.4 Financial Overview

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 Novartis AG

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Products and Services

14.5.4 Financial Overview

14.5.5 SWOT Analysis

14.5.6 Key Developments

14.6 Clearside Biomedical, Inc.

14.6.1 Key Facts

14.6.2 Business Description

14.6.3 Products and Services

14.6.4 Financial Overview

14.6.5 SWOT Analysis

14.6.6 Key Developments

15. Appendix

15.1 About The Insight Partners

15.2 Glossary of Terms

LIST OF TABLES

Table 1. Germany Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology US$ Million)

Table 2. Germany and Middle East and Africa Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million).

Table 3. Germany and Middle East and Africa Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million).

Table 4. Germany Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User US$ Million)

Table 5. UK Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology US$ Million)

Table 6. UK Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million).

Table 7. UK Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million).

Table 8. UK Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User US$ Million)

Table 9. France Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 10. France Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million)

Table 11. France Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million)

Table 12. France Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User (US$ Million)

Table 13. Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 14. Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million)

Table 15. Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million)

Table 16. Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User (US$ Million)

Table 17. Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 18. Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million)

Table 19. Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million)

Table 20. Spain Ocular Drug Delivery Market, by End User – Revenue and Forecast to 2028 by End User (USD Million)

Table 21. Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 22. Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Formulation Type (US$ Million)

Table 23. Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Disease Type (US$ Million)

Table 24. Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, by End User (US$ Million)

Table 25. Organic Developments Done By Companies

Table 26. Inorganic Developments Done by Companies

Table 27. Glossary of Terms, Ocular Drug Delivery Market

LIST OF FIGURES

Figure 1. Europe Ocular Drug Delivery Market Segmentation

Figure 2. Europe Ocular Drug Delivery Market Segmentation, By Country

Figure 3. Europe Ocular Drug Delivery Market Overview

Figure 4. Implantable Ocular Drug Delivery Systems Segment Held the Largest Share of the Technology Segment in Ocular Drug Delivery Market

Figure 5. The UK to Show Significant Growth During Forecast Period

Figure 6. Europe Ocular Drug Delivery Market, Industry Landscape

Figure 7. Europe PEST Analysis

Figure 8. Europe Ocular Drug Delivery Market Impact Analysis of Driver and Restraints

Figure 9. Europe Ocular Drug Delivery Market – Revenue Forecast and Analysis – 2020- 2028

Figure 10. Europe Ocular Drug Delivery Market Share by Technology 2021 & 2028 (%)

Figure 11. Implantable Ocular Drug Delivery Systems Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12. Particulate Drug Delivery Systems Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13. Nano-Particle Drug Delivery System Market Revenue and Forecasts to 2028 (US$ Million)

Figure 14. Others Market Revenue and Forecasts to 2028 (US$ Million)

Figure 15. Europe Ocular Drug Delivery Market, By Formulation Type 2021 & 2028 (%)

Figure 16. Liposomes and Nanoparticles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 17. Solution Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18. Emulsion Market Revenue and Forecasts to 2028 (US$ Million)

Figure 19. Suspension Market Revenue and Forecasts to 2028 (US$ Million)

Figure 20. Ointment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21. Europe Ocular Drug Delivery Market Share by Disease Type 2021 & 2028 (%)

Figure 22. Cataract Market Revenue and Forecasts to 2028 (US$ Million)

Figure 23. Dry Eye Syndrome Market Revenue and Forecasts to 2028 (US$ Million)

Figure 24. Macular Degeneration Market Revenue and Forecasts to 2028 (US$ Million)

Figure 25. Glaucoma Market Revenue and Forecasts to 2028 (US$ Million)

Figure 26. Diabetic Retinopathy Market Revenue and Forecasts to 2028 (US$ Million)

Figure 27. Diabetic Macular Edema Market Revenue and Forecasts to 2028 (US$ Million)

Figure 28. Others Market Revenue and Forecasts to 2028 (US$ Million)

Figure 29. Europe Ocular Drug Delivery Market Share, by End User, 2021 and 2028 (%)

Figure 30. Hospitals: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)

Figure 31. Ophthalmic Clinics: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Thousand)

Figure 32. Ambulatory Surgical Centers: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Thousand)

Figure 33. Europe: Ocular Drug Delivery Market Revenue Overview, by Country, 2021 (US$ MILLION)

Figure 34. Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028, By Country (%)

Figure 35. Germany Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

Figure 36. UK Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

Figure 37. France Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

Figure 38. Italy Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

Figure 39. Spain Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

Figure 40. Rest of Europe Ocular Drug Delivery Market Revenue and Forecasts to 2028 (US$ Million)

Figure 41. Impact of COVID-19 Pandemic in European Country Markets

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe ocular drug delivery market
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in Europe ocular drug delivery market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the ocular drug delivery market as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Europe Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software and Serv..	May 2022
Europe Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Electric P..	May 2022
Europe In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe Mixing Configurat..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample